Live Breaking News & Updates on Fabs In Tandem Immunoglobulin|Page 3

Stay updated with breaking news from Fabs in tandem immunoglobulin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EpimAb Biotherapeutics Appoints Jerry Su, Ph.D. as Chief Technology Officer


Published: May 27, 2021
SHANGHAI (BUSINESS WIRE) EpimAb Biotherapeutics, a clinical stage biotech company specializing in bispecific antibodies, today announced the appointment of Jerry Su, Ph.D. as the Chief Technology Officer of EpimAb. Dr. Su joined EpimAb in December 2019 as Senior VP, CMC and led the completion of EpimAb’s early CMC development facility in Suzhou BioBay. In this newly created role, Dr. Su will continue to oversee the company’s CMC development and manufacturing operations.
“Since he joined EpimAb, Jerry contributed significantly to the organizational growth of EpimAb by successfully completing our fully functional CMC development and manufacturing facility in Suzhou BioBay ahead of plan,” said Dr. Chengbin Wu, founder and CEO of EpimAb Biotherapeutics. “We are delighted to promote Jerry to this new role and look forward to his continued contribution and leadership in driving manufacturing strategy as we rapidly advance our pipeline of n ....

United States , Chengbin Wu , Epimab Biotherapeutics , University Of Chemical Technology , Zhejiang Huahai Biopharmaceuticals Co , Virginia University , Tianjin University , Epimab Biotherapeutics Inc , Suzhou Biobay , Zhejiang Huahai Biopharmaceuticals , West Virginia University , Beijing University , Chemical Technology , Fabs In Tandem Immunoglobulin , Pimab Biotherapeutics Appoints Jerry Su , Hd As Chief Technology Officer , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் இரசாயன தொழில்நுட்பம் , வர்ஜீனியா பல்கலைக்கழகம் , மேற்கு வர்ஜீனியா பல்கலைக்கழகம் , பெய்ஜிங் பல்கலைக்கழகம் , இரசாயன தொழில்நுட்பம் ,